Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$254.38M
Total Bought:
$78.57M
Total Sold:
$70.76M
Net Transaction:
+$7.81M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
LENZ Therapeutics, Inc.(LENZ)01,068,675+1,068,675$0$23.86M9.38%+$23.86M
Eli Lilly and Company(LLY)26,56525,665-900$15.49M$19.97M7.85%+$4.48M
Boundless Bio, Inc.(BOLD)0855,875+855,875$0$12.20M4.79%+$12.20M
UnitedHealth Group Incorporated(UNH)18,92523,175+4,250$9.96M$11.46M4.51%+$1.50M
Merck & Co., Inc.(MRK)79,50086,500+7,000$8.67M$11.41M4.49%+$2.75M
Abbott Labs68,99870,248+1,250$7.59M$7.98M3.14%+$389.8K
Johnson & Johnson(JNJ)53,85047,850-6,000$8.44M$7.57M2.98%-$871.1K
Mineralys Therapeutics, Inc.(MLYS)605,606552,256-53,350$5.21M$7.13M2.80%+$1.92M
Regeneron Pharmaceuticals, Inc.(REGN)3,8357,075+3,240$3.37M$6.81M2.68%+$3.44M
AbbVie Inc.(ABBV)46,30035,200-11,100$7.18M$6.41M2.52%-$765.2K
Boston Scientific Corporation(BSX)91,47686,476-5,000$5.29M$5.92M2.33%+$634.5K
Thermo Fisher Scientific Inc.(TMO)9,01510,015+1,000$4.79M$5.82M2.29%+$1.04M
Pfizer Inc.(PFE)189,400189,4000$5.45M$5.26M2.07%-$197.0K
Amgen Inc.(AMGN)28,68516,085-12,600$8.26M$4.57M1.80%-$3.69M
BioMarin Pharmaceutical Inc.(BMRN)50,07051,640+1,570$4.83M$4.51M1.77%-$317.5K
DexCom, Inc.(DXCM)29,40032,400+3,000$3.65M$4.49M1.77%+$845.6K
Danaher Corporation(DHR)14,97517,725+2,750$3.46M$4.43M1.74%+$962.0K
Zimmer Biomet Holdings, Inc.(ZBH)029,750+29,750$0$3.93M1.54%+$3.93M
argenx SEADR(ARGX)10,0279,307-720$3.81M$3.66M1.44%-$150.2K
IQVIA Holdings Inc.(IQV)16,60014,100-2,500$3.84M$3.57M1.40%-$275.2K
Medtronic plcSHS(MDT)40,05138,051-2,000$3.30M$3.32M1.30%+$16.7K
Insulet Corporation(PODD)12,95018,100+5,150$2.81M$3.10M1.22%+$292.4K
Vertex Pharmaceuticals Incorporated(VRTX)9,2197,210-2,009$3.75M$3.01M1.18%-$737.3K
Cytokinetics, Incorporated(CYTK)7,01342,583+35,570$585.5K$2.99M1.17%+$2.40M
Progyny Inc076,000+76,000$0$2.90M1.14%+$2.90M
Gilead Sciences, Inc.(GILD)40,90538,705-2,200$3.31M$2.84M1.11%-$478.6K
Alnylam Pharmaceuticals, Inc.(ALNY)22,64018,460-4,180$4.33M$2.76M1.08%-$1.57M
ICON Public Limited CompanySHS(ICLR)10,2037,943-2,260$2.89M$2.67M1.05%-$219.7K
Centene Corporation(CNC)034,000+34,000$0$2.67M1.05%+$2.67M
Amicus Therapeutics
COM
156,769221,044+64,275$2.22M$2.60M1.02%+$379.3K
Inari Med Inc052,500+52,500$0$2.52M0.99%+$2.52M
Intuitive Surgical, Inc.(ISRG)06,100+6,100$0$2.43M0.96%+$2.43M
Stryker Corporation(SYK)06,600+6,600$0$2.36M0.93%+$2.36M
MoonLake ImmunotherapeuticsCL A(MLTX)30,00546,295+16,290$1.81M$2.33M0.91%+$513.4K
GoodRx Holdings, Inc.(GDRX)364,000321,000-43,000$2.44M$2.28M0.90%-$159.7K
Sarepta Therapeutics, Inc.(SRPT)21,54117,291-4,250$2.08M$2.24M0.88%+$161.3K
Option Care Health, Inc.(OPCH)64,00064,0000$2.16M$2.15M0.84%-$9.6K
ARS Pharmaceuticals, Inc.(SPRY)354,641204,437-150,204$1.94M$2.09M0.82%+$145.9K
Arvinas, Inc.(ARVN)66,00048,780-17,220$2.72M$2.01M0.79%-$702.9K
Vera Therapeutics, Inc.CL A(VERA)124,15144,901-79,250$1.91M$1.94M0.76%+$26.7K
EyePoint, Inc.(EYPT)81,16092,340+11,180$1.88M$1.91M0.75%+$33.1K
Alphatec Holdings, Inc.(ATEC)0136,000+136,000$0$1.88M0.74%+$1.88M
Iteos Therapeutics220,056133,966-86,090$2.41M$1.83M0.72%-$582.3K
Elevance Health, Inc.(ELV)03,500+3,500$0$1.81M0.71%+$1.81M
Cogent Biosciences, Inc.(COGT)0263,700+263,700$0$1.77M0.70%+$1.77M
Arcus Biosciences, Inc.(RCUS)97,43593,635-3,800$1.86M$1.77M0.69%-$93.2K
AstraZeneca PLCADR(AZN)26,13024,430-1,700$1.76M$1.66M0.65%-$104.7K
Humana Inc.(HUM)8,2254,751-3,474$3.77M$1.65M0.65%-$2.12M
Acelyrin Inc325,549244,000-81,549$2.43M$1.65M0.65%-$781.6K
Olema Pharmaceuticals, Inc.(OLMA)19,230139,980+120,750$269.8K$1.58M0.62%+$1.31M
Moderna, Inc.(MRNA)16,10014,740-1,360$1.60M$1.57M0.62%-$30.5K
Biogen Inc.(BIIB)15,8276,967-8,860$4.10M$1.50M0.59%-$2.59M
Edwards Lifescience21,90015,650-6,250$1.67M$1.50M0.59%-$174.4K
Effector Therapeutic095,305+95,305$0$1.37M0.54%+$1.37M
Turnstone Biologics517,648517,6480$1.32M$1.36M0.53%+$38.8K
Summit Therapeutics Inc.(SMMT)30,000315,000+285,000$78.3K$1.30M0.51%+$1.23M
Altimmune, Inc.(ALT)170,80092,240-78,560$1.92M$939.0K0.37%-$982.5K
Verastem, Inc.(VSTM)203,32774,200-129,127$1.66M$875.6K0.34%-$779.5K
Illumina, Inc.(ILMN)6,6006,280-320$919.0K$862.4K0.34%-$56.6K
SanofiADR(SNY)14,09012,670-1,420$700.7K$615.8K0.24%-$84.9K
Ascendis Pharma A/SADR(ASND)4,4414,011-430$559.3K$606.3K0.24%+$47.0K
United Therapeutics Corporation(UTHR)2,8152,595-220$619.0K$596.1K0.23%-$22.9K
Royalty Pharma plcCL A(RPRX)20,57019,420-1,150$577.8K$589.8K0.23%+$12.0K
Vaxcyte, Inc.(PCVX)8,0508,500+450$505.5K$580.6K0.23%+$75.1K
Neurocrine Biosciences, Inc.(NBIX)4,4454,195-250$585.7K$578.6K0.23%-$7.1K
BeOne Medicines AGADR(ONC)3,7523,692-60$676.7K$577.4K0.23%-$99.3K
Apellis Pharmaceutic
COM
5,2209,670+4,450$312.5K$568.4K0.22%+$255.9K
Incyte Corporation(INCY)10,1059,405-700$634.5K$535.8K0.21%-$98.7K
Medpace Holdings, Inc.(MEDP)1,3711,291-80$420.3K$521.8K0.21%+$101.5K
Roivant Sciences Ltd.SHS(ROIV)36,45749,457+13,000$409.4K$521.3K0.20%+$111.9K
BridgeBio Pharma, Inc.(BBIO)12,95516,105+3,150$523.0K$498.0K0.20%-$25.0K
Intra Cellular Thera7,4207,080-340$531.4K$489.9K0.19%-$41.5K
Jazz Pharmaceuticals plcSHS USD(JAZZ)4,0943,894-200$503.6K$468.9K0.18%-$34.6K
Insmed Incorporated(INSM)13,81116,421+2,610$428.0K$445.5K0.18%+$17.5K
Ionis Pharmaceuticals, Inc.(IONS)6,48010,100+3,620$327.8K$437.8K0.17%+$110.0K
Blueprint Medicines2,4704,410+1,940$227.8K$418.3K0.16%+$190.5K
Revolution Medicines, Inc.(RVMD)13,71012,910-800$393.2K$416.1K0.16%+$22.9K
Dr. Reddy's Laboratories LimitedADR(RDY)4,5005,500+1,000$313.1K$403.4K0.16%+$90.3K
Rocket Pharmaceuticals, Inc.(RCKT)12,28014,810+2,530$368.0K$399.0K0.16%+$30.9K
Alkermes plcSHS(ALKS)15,33014,230-1,100$425.3K$385.2K0.15%-$40.0K
BioNTech SEADR(BNTX)3,7253,525-200$393.1K$325.2K0.13%-$68.0K
Exelixis, Inc.(EXEL)13,99013,140-850$335.6K$311.8K0.12%-$23.8K
Madrigal Pharmaceuticals, Inc.(MDGL)1,2011,131-70$277.9K$302.0K0.12%+$24.1K
Scholar Rock Holding Corporation(SRRK)015,400+15,400$0$273.5K0.11%+$273.5K
Structure TherapeuADR3,4005,964+2,564$138.6K$255.6K0.10%+$117.0K
Denali Therapeutics Inc.(DNLI)12,88112,081-800$276.4K$247.9K0.10%-$28.5K
Intellia Therapeutics, Inc.(NTLA)9,3008,800-500$283.6K$242.1K0.10%-$41.5K
Halozyme Therapeutics, Inc.(HALO)6,0305,680-350$222.9K$231.1K0.09%+$8.2K
Arrowhead Pharmaceuticals, Inc.(ARWR)8,1827,682-500$250.4K$219.7K0.09%-$30.7K
Kyverna Therapeutics, Inc.(KYTX)07,000+7,000$0$173.9K0.07%+$173.9K
Legend Biotech CorporationADR(LEGN)3,0003,0000$180.5K$168.3K0.07%-$12.2K
Zai Lab LimitedADR(ZLAB)4,0002,000-2,000$109.3K$32.0K0.01%-$77.3K
Acadia Pharmaceutcls15,0600-15,060$471.5K$0—-$471.5K
Allakos Inc752,3810-752,381$2.05M$0—-$2.05M
Amylyx Pharmaceuticals, Inc.(AMLX)84,0550-84,055$1.24M$0—-$1.24M
Annexon, Inc.(ANNX)650,9110-650,911$2.96M$0—-$2.96M
Axonics Inc32,8000-32,800$2.04M$0—-$2.04M
BioAtla, Inc.(BCAB)706,0620-706,062$1.74M$0—-$1.74M
CONMED Corporation(CNMD)18,1000-18,100$1.98M$0—-$1.98M
Edgewise Therapeutics, Inc.(EWTX)327,8010-327,801$3.59M$0—-$3.59M
Page 1 of 2
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q1 2024 | TickerTrail